VRTX - Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 20 Years | Benzinga
Vertex Pharmaceuticals (NASDAQ:VRTX) has outperformed the market over the past 20 years by 12.7% on an annualized basis producing an average annual return of 20.87%. Currently, Vertex Pharmaceuticals has a market capitalization of $120.90 billion.
Buying $1000 In VRTX: If ...